PALB2 and familial pancreatic carcinoma: Screening for pancreatic cancer with an annual MRI and/or endoscopic ultrasound from the age of 50 (or 5–10 years younger than the affected relative) can also be considered, when at least one first- or second-degree, presumably PALB2-positive relative develops exocrine pancreatic cancer (39).